From: Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
Progression free survival | Overall survival | |||||||
---|---|---|---|---|---|---|---|---|
HR | 95,0 % CI for HR | Sig. | HR | 95,0 % CI for HR | Sig. | |||
Lower | Upper | Lower | Upper | |||||
Age | 1.019 | 0.986 | 1.053 | 0.266 | 1.028 | 1.003 | 1.054 | 0.03 |
Histology | 0.641 | 0.003 | ||||||
Mucinous versus serous | 1.134 | 0.498 | 2.583 | 0.765 | 1.223 | 0.605 | 2.471 | 0.575 |
Endometroid versus serous | 0 | 0 | . | 0.983 | 21.448 | 3.539 | 130.006 | 0.001 |
Clear-cell versus serous | 0.542 | 0.187 | 1.575 | 0.261 | 0.559 | 0.228 | 1.369 | 0.203 |
Adenocarcinoma unspecified versus serous | 1.099 | 0.231 | 5.226 | 0.906 | 1.335 | 0.369 | 4.835 | 0.66 |
Differentiation | 3.266 | 0.778 | 13.716 | 0.106 | 1.702 | 0.674 | 4.297 | 0.26 |
CA 125 | ||||||||
<35 | 0.362 | 0.635 | ||||||
35–200 | 0.57 | 0.216 | 1.499 | 0.254 | 0.847 | 0.391 | 1.831 | 0.672 |
>200 | 0.62 | 0.254 | 1.515 | 0.295 | 0.709 | 0.34 | 1.478 | 0.359 |
Ascites | 1.919 | 0.836 | 4.401 | 0.124 | 1.75 | 0.877 | 3.489 | 0.112 |
FIGO | ||||||||
IIB | 0.076 | 0.044 | ||||||
III | 0.311 | 0.077 | 1.26 | 0.102 | 0.294 | 0.101 | 0.854 | 0.024 |
IV | 1.06 | 0.371 | 3.028 | 0.914 | 0.839 | 0.389 | 1.807 | 0.653 |
Cytoreduction | 1.882 | 0.939 | 3.774 | 0.075 | 1.696 | 0.935 | 3.076 | 0.082 |
MMP-14 Overall Score | 1.538 | 0.777 | 3.043 | 0.216 | 0.945 | 0.551 | 1.624 | 0.839 |
MMP-14 stroma | 1.421 | 0.99 | 2.039 | 0.057 | 0.695 | 0.371 | 1.299 | 0.254 |
MMP-2 Overall Score | 22.901 | 0 | #######* | 0.668 | 0.879 | 0.395 | 1.953 | 0.751 |
MMP-2 stroma | 1.214 | 0.807 | 1.828 | 0.352 | 1.15 | 0.832 | 1.59 | 0.399 |